X0306 4 2015-02-27 1 0000069499 MYLAN INC. MYL 0001162304 HIGGINS MELINA E 1000 MYLAN BLVD CANONSBURG PA 15317 1 0 0 0 Common Stock 2015-02-27 4 D 0 8351 D 0 D Common Stock 2015-02-27 4 D 0 19000 D 0 I By Husband Non-Employee Director Stock Option - Right to Buy 31.63 2015-02-27 4 D 0 6623 D 2023-05-28 Common Stock 6623 0 D Non-Employee Director Stock Option - Right to Buy 45.72 2015-02-27 4 D 0 2974 D 2024-04-11 Common Stock 2974 0 D On February 27, 2015 (the "Closing Date"), Mylan N.V. completed the transaction (the "Transaction") by which it acquired Mylan Inc. and Abbott Laboratories' ("Abbott") non-U.S. developed markets specialty and branded generics business (the "Business"). Pursuant to the terms of the Amended and Restated Business Transfer Agreement and Plan of Merger, dated as of November 4, 2014, by and among Mylan Inc., New Moon B.V. (which has been renamed Mylan N.V. and is referred to herein as "Mylan"), Moon of PA Inc. ("Merger Sub"), and Abbott, on the Closing Date, Mylan acquired the Business and Merger Sub merged with and into Mylan Inc., with Mylan Inc. surviving as a wholly owned indirect subsidiary of Mylan and each share of Mylan Inc. common stock issued and outstanding was cancelled and automatically converted into and became the right to receive one Mylan ordinary share (the "Merger"). (Continued in Footnote 2) In connection with the Transaction, Mylan Inc. and the Business have been reorganized under Mylan, a new public company organized in the Netherlands. This report is being filed by the reporting person solely to report the disposition of shares of Mylan Inc. common stock in connection with the Transaction. The reporting person will file a separate Form 4 to reflect the corresponding acquisition of securities of Mylan in connection with the Transaction. Represents shares of Mylan Inc. common stock that were exchanged on a one-for-one basis for Mylan ordinary shares in connection with the Transaction. On the effective date of the Merger, the closing price of MYL was $57.33 per share. Represents stock options of Mylan Inc. common stock that were exchanged for stock options of Mylan ordinary shares having substantially the same terms in connection with the Transaction. These options vested in full on May 28, 2014. These options will vest in full on April 11, 2015. /s/ Bradley L. Wideman, by power of attorney 2015-02-27